Our founders are keen observers of the pharmaceutical market and the public and medical community attitude toward cannabis for medical and therapeutic use. We began creating the company that would become Aphelion in 2014. There were several early iterations, including a scaled mockup of process flow in an empty airplane hangar.
With seed funding from some business-savvy and forward-thinking individuals, our facility was built through 2018-19. We have meticulously submitted all the required paperwork and are currently undergoing the rigorous licensing process from Health Canada.
We take quality, and the rules and regulations that protect it, very seriously. To an obsessive degree. We follow all the rules set out by every level of government. Every. Single. Time. (We were the kids who lined up early at the end of recess.) This meticulous commitment results in a consistent, reliable product and peace of mind for stakeholders.
People are the reason we do this.
Treatment of pain; relief from side effects of cancer treatment; help with sleep or anxiety. There are myriad reasons health care practitioners direct patients to medical cannabis, and Aphelion is committed to listening, providing information, and supplying reliable therapeutics to help.
Our management team combines experience in government, the Canadian Forces, business, academia, and biotech. Our company is where a sense of adventure meets a sense of responsibility.
We are building a sustainable business, infusing our core values every step of the way to generate prosperity.
